Dumont & Blake Investment Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $663K | Sell |
|
|||||
|
2025
Q2 | $652K | Buy |
|
|||||
|
2025
Q1 | $644K | Buy |
|
|||||
|
2024
Q4 | $789K | Sell |
|
|||||
|
2024
Q3 | $859K | Sell |
|
|||||
|
2024
Q2 | $1.8M | Buy |
|
|||||
|
2024
Q1 | $1.2M | Buy |
|
|||||
|
2023
Q4 | $1.03M | Sell |
|
|||||
|
2023
Q3 | $880K | Buy |
|
|||||
|
2023
Q2 | $938K | Buy |
|
|||||
|
2023
Q1 | $898K | Buy |
|
|||||
|
2022
Q4 | $515K | Sell |
|
|||||
|
2022
Q3 | $466K | Buy |
|